Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy

Published:2011-03 Issue:2 Volume:5 Page:97-104
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Kostis William J.,Moreyra Abel E.,Cheng Jerry Q.,Dobrzynski Jeanne M.,Kostis John B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference33 articles.

1. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis;Lancet,2008

2. Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy;Kizer;Am J Cardiol,2010

3. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-todate meta-analysis;Amarenco;Stroke,2004

4. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials;Briel;JAMA,2006

5. Jupiter Study Group. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein;Ridker;N Engl J Med,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations of Randomized Clinical Trials;The American Journal of Cardiology;2020-08

2. The Legacy Effect in Treating Hypercholesterolemia;Journal of Cardiovascular Pharmacology and Therapeutics;2020-02-28

3. Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed;Diabetes Spectrum;2020-02-01

4. Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension;Current Hypertension Reports;2019-10-10

5. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study;Scientific Reports;2019-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3